These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19577021)

  • 1. Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial.
    Payan CA; Hogrel JY; Hammouda EH; Lacomblez L; Ollivier G; Doppler V; Eymard B; Attarian S; Pouget J; Desnuelle C; Laforêt P
    Arch Phys Med Rehabil; 2009 Jul; 90(7):1094-101. PubMed ID: 19577021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.
    Kissel JT; McDermott MP; Mendell JR; King WM; Pandya S; Griggs RC; Tawil R;
    Neurology; 2001 Oct; 57(8):1434-40. PubMed ID: 11673585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength training and albuterol in facioscapulohumeral muscular dystrophy.
    van der Kooi EL; Vogels OJ; van Asseldonk RJ; Lindeman E; Hendriks JC; Wohlgemuth M; van der Maarel SM; Padberg GW
    Neurology; 2004 Aug; 63(4):702-8. PubMed ID: 15326246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot trial of salbutamol in central core and multi-minicore diseases.
    Messina S; Hartley L; Main M; Kinali M; Jungbluth H; Muntoni F; Mercuri E
    Neuropediatrics; 2004 Oct; 35(5):262-6. PubMed ID: 15534757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy.
    van der Kooi EL; Kalkman JS; Lindeman E; Hendriks JC; van Engelen BG; Bleijenberg G; Padberg GW
    J Neurol; 2007 Jul; 254(7):931-40. PubMed ID: 17361345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular electrical stimulation training: a safe and effective treatment for facioscapulohumeral muscular dystrophy patients.
    Colson SS; Benchortane M; Tanant V; Faghan JP; Fournier-Mehouas M; Benaïm C; Desnuelle C; Sacconi S
    Arch Phys Med Rehabil; 2010 May; 91(5):697-702. PubMed ID: 20434605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment for facioscapulohumeral muscular dystrophy.
    Rose MR; Tawil R
    Cochrane Database Syst Rev; 2004; 2004(2):CD002276. PubMed ID: 15106171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a French isometric strength normative database for adults using quantitative muscle testing.
    Hogrel JY; Payan CA; Ollivier G; Tanant V; Attarian S; Couillandre A; Dupeyron A; Lacomblez L; Doppler V; Meininger V; Tranchant C; Pouget J; Desnuelle C
    Arch Phys Med Rehabil; 2007 Oct; 88(10):1289-97. PubMed ID: 17908571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.
    Perkins GD; McAuley DF; Thickett DR; Gao F
    Am J Respir Crit Care Med; 2006 Feb; 173(3):281-7. PubMed ID: 16254268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
    Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
    Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral salbutamol for symptomatic relief in mild bronchiolitis a double blind randomized placebo controlled trial.
    Gupta P; Aggarwal A; Gupta P; Sharma KK
    Indian Pediatr; 2008 Jul; 45(7):547-53. PubMed ID: 18695272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.
    Kissel JT; McDermott MP; Natarajan R; Mendell JR; Pandya S; King WM; Griggs RC; Tawil R
    Neurology; 1998 May; 50(5):1402-6. PubMed ID: 9595995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD).
    Skalsky AJ; Abresch RT; Han JJ; Shin CS; McDonald CM
    Neuromuscul Disord; 2008 Nov; 18(11):873-80. PubMed ID: 18818077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of efficacy of salbutamol via metered dose inhaler with volumatic spacer and via dry powder inhaler, easyhaler, to nebulization in mild to moderate severity acute asthma exacerbation in childhood.
    Vangveeravong M
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S115-23. PubMed ID: 19253506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol.
    Schaffler K; Reeh PW
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):673-82. PubMed ID: 2893778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel quantitative assessment of the tremorogenic effects of the beta 2-mimetics clenbuterol and salbutamol after oral administration].
    Schaffler K; Schuster D
    Arzneimittelforschung; 1985; 35(8):1299-302. PubMed ID: 3907640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of motor unit potential analysis in facioscapulohumeral muscular dystrophy.
    Podnar S; Zidar J
    Muscle Nerve; 2006 Oct; 34(4):451-6. PubMed ID: 16830333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.